InvivoSciences, Inc. (IVS)

InvivoSciences, Inc. (IVS) is a precision medicine company personalizing the drug development process by introducing patient-derived and gene-edited human samples, including 3D engineered microtissues. Our unique integration of cell & tissue handling automation, tissue phenotyping assays, computational biology (AI), and human organ/tissue data enables rapid identification of safety and efficacy profile of a given treatment for specific patient group cost-effectively before expensive clinical trials. 3-D Human micro tissue technologies accelerating personalized drug discovery and development. These innovations assist our partners deliver better medicines faster and cost effectively. A research team lead by Dr. Bailly at the University College London Institute of Ophthalmology uses IVS’ micro mechanical assays to uncover the mechanism of Trachoma. Little is known about the molecular mechanisms underlying progressive fibrosis in Trachoma which is the leading cause of blindness worldwide.